Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Exercise on Prevention of Weight Gain

This study has been completed.
National Institutes of Health (NIH)
Information provided by:
University of Pittsburgh Identifier:
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

September 12, 2005
September 12, 2005
January 2003
Not Provided
body weight
Same as current
No Changes Posted
  • fitness
  • physical activity
  • dietary intake
  • mediators
Same as current
Not Provided
Not Provided
Effect of Exercise on Prevention of Weight Gain
Effect of Exercise on Prevention of Weight Gain
The purpose of this study is to examine the dose-response of exercise on prevention of weight gain in overweight adults.
Not Provided
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Weight Loss
Behavioral: behavioral exercise intervention
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
December 2006
Not Provided

Inclusion Criteria:

  1. Female or Male
  2. 18-55 years of age
  3. BMI = 25-29.9 kg/m2
  4. Ability to provide informed consent.
  5. Ability to provide consent from their personal physician to participate in this study.

Exclusion Criteria:

  1. Reporting regular exercise participation of at least 20 minutes per day on at least 3 days per week during the previous six months. (This study is designed to recruit relatively sedentary adults.)
  2. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
  3. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, this will be confirmed with the urine pregnancy test that will be conducted prior to the baseline DEXA.)
  4. Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.
  5. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
  6. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
  7. History of myocardial infarction or valvular disease.
  8. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
18 Years to 55 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
R01HL070257-01A1, R01HL070257-01A1
Not Provided
Not Provided
Not Provided
Not Provided
University of Pittsburgh
National Institutes of Health (NIH)
Principal Investigator: John M Jakicic, Ph.D. University of Pittsburgh
University of Pittsburgh
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP